SLC1A4 Gene Developmental Delay and Microcephaly
At DNA Labs UAE, we offer the SLC1A4 Gene Developmental Delay and Microcephaly genetic test. This test is designed to identify mutations in the SLC1A4 gene, which has been linked to developmental delay and microcephaly.
Test Details
The SLC1A4 gene encodes a protein called glutamate transporter 1 (GLT-1), responsible for transporting the neurotransmitter glutamate out of the synapse and into surrounding cells. Mutations in SLC1A4 have been associated with developmental delay and microcephaly, a condition characterized by a smaller than average head size and often accompanied by intellectual disability.
Our SLC1A4 Gene Developmental Delay and Microcephaly test utilizes NGS (next-generation sequencing) technology. This method involves sequencing the entire coding region of the gene to identify any changes or variations that may be present. NGS testing is highly sensitive and specific, making it an effective tool for diagnosing a wide range of genetic disorders.
Test Components and Price
The SLC1A4 Gene Developmental Delay and Microcephaly genetic test is priced at 4400.0 AED.
Sample Condition
We accept blood samples, extracted DNA, or one drop of blood on an FTA card for this test.
Report Delivery
Test results are typically delivered within 3 to 4 weeks.
Test Type and Department
The SLC1A4 Gene Developmental Delay and Microcephaly test falls under the category of Neurological Disorders and is conducted by our Genetics department.
Referring Doctor
This test is typically recommended by a Neurologist.
Pre-Test Information
Prior to undergoing the SLC1A4 Gene Developmental Delay and Microcephaly test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by SLC1A4-related developmental delay and microcephaly.
Treatment and Management
If a mutation is identified in the SLC1A4 gene, genetic counseling may be recommended to help individuals and families understand the implications of the diagnosis. Treatment options may include early intervention services, educational support, and therapy to address developmental delays and intellectual disability.
| Test Name | SLC1A4 Gene Developmental delay and microcephaly SLC1A4 related Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for SLC1A4 Gene Developmental delay and microcephaly, SLC1A4 related NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SLC1A4 Gene Developmental delay and microcephaly, SLC1A4 related |
| Test Details |
SLC1A4 is a gene that encodes a protein called glutamate transporter 1 (GLT-1). GLT-1 is responsible for transporting the neurotransmitter glutamate out of the synapse and into surrounding cells, where it can be metabolized or recycled. Mutations in SLC1A4 have been linked to developmental delay and microcephaly, which is a condition characterized by a smaller than average head size and often associated with intellectual disability. NGS (next-generation sequencing) genetic testing can be used to identify mutations in the SLC1A4 gene. This type of testing involves sequencing the entire coding region of the gene to identify any changes or variations that may be present. NGS testing is a highly sensitive and specific method for identifying genetic mutations, and can be used to diagnose a wide range of genetic disorders. If a mutation is identified in the SLC1A4 gene, genetic counseling may be recommended to help individuals and families understand the implications of the diagnosis and to explore options for treatment and management of the condition. Treatment may include early intervention services, educational support, and therapy to address developmental delays and intellectual disability. |